LENOGRASTIM - (First line)

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 13·4 million units (105 micrograms), 33·6 million units (263 micrograms) (s)

FILGRASTIM

Important: Therapy notes

MHRA advice: Filgrastim and pegfilgrastim: risk of capillary leak syndrome (December 2014) (www.gov.uk).

  • Filgrastim should be prescribed by brand name.

Important: Formulation and dosage details

Formulation:

Solution for injection 30 million units (300 micrograms/1mL) (Neupogen®) (s)

Important: Formulation and dosage details

Formulation:

Solution for injection pre-filled syringe 30 million units (300 micrograms/0·5mL) (Zarzio®) (s)

Important: Formulation and dosage details

Formulation:

Solution for injection pre-filled syringe 48 million units (480 micrograms/0·5mL) (Neupogen®, Zarzio®) (s)

LIPEGFILGRASTIM

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 10mg/mL (s)

Important: Formulation and dosage details

Formulation:

Injection pre-filled syringe 6mg/0·6mL (s)

Editorial Information

Document Id: F290